Scarica l'app Stockscreener
2.68
0.37%
-0.010
Dopo l'orario di chiusura:
2.72
0.04
+1.49%
Precedente Chiudi:
$2.69
Aprire:
$2.63
Volume 24 ore:
7.98M
Relative Volume:
3.80
Capitalizzazione di mercato:
$902.00M
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-6.5366
EPS:
-0.41
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
+2.68%
1M Prestazione:
+3.88%
6M Prestazione:
-11.55%
1 anno Prestazione:
+90.07%
Intervallo 1D:
$2.57
$2.76
Intervallo di 1 settimana:
$2.51
$2.865
Portata 52W:
$1.43
$4.1598
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.68 | 902.00M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
Wellington Management Group LLP Purchases 283,642 Shares of Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio (NYSE:NUVB) Trading Up 5%Still a Buy? - MarketBeat
Verition Fund Management LLC Sells 13,409 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Charles Schwab Investment Management Inc. Increases Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio's SWOT analysis: taletrectinib drives stock outlook amid pipeline shifts - Investing.com
Clear Street sets Nuvation Bio at Buy with $5 target By Investing.com - Investing.com South Africa
Clear Street sets Nuvation Bio at Buy with $5 target - Investing.com
Point72 Asset Management L.P. Takes Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio Inc (NYSE: NUVB) Drops -1.75 Percent In Recent Session, Why Are You Interested? - Stocks Register
Frazier Life Sciences Management L.P. Acquires New Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio (NYSE:NUVB) Shares Gap Down – What’s Next? - Defense World
Wexford Capital LP Has $1.49 Million Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Fmr LLC Has $66.96 Million Stake in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio (NYSE:NUVB) Shares Gap DownHere's What Happened - MarketBeat
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
Nuvation Bio’s Q3 2024 Highlights and Future Prospects - TipRanks
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - Simply Wall St
Nuvation Bio (NYSE:NUVB) Shares Down 7.7%Time to Sell? - MarketBeat
Nuvation Bio's SWOT analysis: taletrectinib drives stock potential amid challenges - Investing.com India
FMR LLC Bolsters Stake in Nuvation Bio Inc - GuruFocus.com
Nuvation Bio to Present at the Jefferies London Healthcare Conference - Business Wire
What is Wedbush's Estimate for Nuvation Bio FY2024 Earnings? - MarketBeat
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade - MarketBeat
Nuvation Bio’s Global Challenges: Navigating Risks in China Amid Geopolitical Tensions - TipRanks
Royal Bank of Canada Increases Nuvation Bio (NYSE:NUVB) Price Target to $6.00 - MarketBeat
Nuvation Bio reports Q3 EPS (15c, consensus (13c) - TipRanks
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline - Yahoo Finance
11 Best NYSE Penny Stocks to Buy Right Now - Insider Monkey
Nuvation Bio (NYSE:NUVB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Nuvation Bio Inc. (NYSE:NUVB) Short Interest Update - MarketBeat
Nuvation Bio (NYSE:NUVB) Stock Price Down 4.3%What's Next? - MarketBeat
Wedbush Analysts Boost Earnings Estimates for Nuvation Bio - MarketBeat
What is Wedbush's Forecast for Nuvation Bio FY2028 Earnings? - MarketBeat
Nuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from Wedbush - MarketBeat
Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market (NYSE:NUVB) - Seeking Alpha
Financial Survey: Neoleukin Therapeutics (NASDAQ:NLTX) & Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.8%Time to Sell? - MarketBeat
This Biotech Stock Insider is Buying Shares, Should You? - Inkl
This Biotech Stock Insider Is Buying Shares, Should You? - Barchart
Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? - Insider Monkey
Robert Mashal Spends US$220k On Nuvation Bio Shares - Simply Wall St
Robert Mashal At Nuvation Bio Tops Up Holding By US$220k - Yahoo Finance
Is Nuvation Bio Inc (NUVB) a opportunity to investors? - US Post News
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):